As the systematic review noted: No clinical safety data were found. When the FDA says insufficient evidence, they mean itwe literally do not have the data to know whether chronic BPC-157 use causes problems that emerge years down the road
And anyone with severe renal impairment should discuss both compounds with their physician before proceeding
Disclaimer: The information presented in this article is for educational and research purposes only
12 The Medical Board ruled against a patient who claimed his deteriorating health was due to the continued treatment with B12 injections
Harlem, Norridge, IL 60706 708-922-0911 Palatine 770 E Dundee Rd, Palatine, IL 60074 708-922-0911 Pullman 10834 South Doty Avenue, Chicago, IL 60628 708-922-0911 Warsaw 2680 Escalade Way, Warsaw, IN 46582 708-922-0911 Zion 2015 Sheridan Rd, Zion, IL 60099 708-922-0911 Healthier teams, less downtime Partner with Local MD for pre-employment and DOT physicals, drug screening, injury care, and on-site programs built around your operations
published in Frontiers in Physiology confirmed that BPC-157 dose- and time-dependently increased GHR expression in isolated rat Achilles tendon fibroblasts at both mRNA and protein level, and that GH added to BPC-157-treated fibroblasts produced significant, dose-dependent increases in cell proliferation establishing GHR upregulation as a specific molecular mechanism through which BPC-157 enhances local tissue sensitivity to growth hormone signalling